The ∆ F508is the most common defect in the cystic fibrosis (CF) 
INTRODUCTION
Cystic fibrosis (CF) is an inherited disorder characterized by progressive lung disease, pancreatic insufficiency, impaired growth, elevated sweat electrolyte values and other less common clinical findings (4, 9) . The gene and its DNA sequence have been characterized (9, 16) . A mutant allele frequency of 0.022 in the United States was derived from the autosomal recessive mode of inheritance (1) . Although the frequency of cystic fibrosis is not uniformly high among all Caucasian populations, a consensus estimate is that it occurs once in 2000 live births. Approximately 70% of the CF gene mutations in cystic fibrosis patients correspond to a specific deletion of three base pairs ( ∆ F508 ), which results in the loss of a phenylalanine residue at amino acid position 508 (8) . A simple and reliable test to identify mutations in the CF gene has important implications for genetic diagnosis at the DNA level. Although the amplification of polymerase chain reaction (PCR) coupled with DNA sequencing has been the most definitive procedure for identifying abnormal DNA sequences, it remains labor-intensive and expensive for clinical uses (17, 18) . Several alternative approaches have been developed for screening or detecting DNA mutations (2, 3, 8, 10, 11, (13) (14) (15) . Kerem et al. have demonstrated the detection of ∆ F508 by oligonucleotide dot blot hybridization (8) . Since our first demonstration of the specific cleavage of mismatch repair (MR) enzymes in determining a DNA point mutation (7,12), Lishanski et al. used the specific mutS binding to mismatched DNA heteroduplex and showed the resulting mobility shift for screening of the CF gene mutation (11) . Recently, we cloned the mutYgene and overexpressed and purified the protein to near homogeneity for the assay (5, 19) . This purified mutY enzyme is free of exonuclease activity and does not cut single-stranded (ss) DNA. In addition to determining a point mutation, the specific cleavages at the mispair of a known probe will also reveal a specific complementary nucleic acid sequence in the target DNA samples. The addition of ammonium acetate (AA) amplifiers in the assay for recycling the target DNA further increases the assay sensitivity (6) . This study demonstrates a modified procedure that detects the base deletion for ∆ F508 . The amplification of sensitivity and the differentiation for the three genotype groups are discussed.
MATERIALS AND METHODS

Enzymes, Chemicals and Reagent
MutY MR enzyme was overproduced in an E. coli HMS174 host that harbored a mutYoverexpression vector. The procedures of preparation, isolation and purification of MutY protein were described previously (19) .
The Sephadex ® G-25 Quick Spin ™ Column, Tris, EDTA, sodium dodecyl sulfate (SDS) and T4 Polynucleotide Kinase (PNK) were purchased from Boehringer Mannheim (Indianapolis, IN, USA). [r-32 P]ATP (3000 Ci/mmol) and acrylamide were obtained from Amersham Pharmacia Biotech (Piscat -away, NJ, USA) and Bio-Rad (Hercules, CA, USA), respectively.
Probes and Targets
The target DNA fragments were prepared by PCR amplification of genomic DNAs previously characterized as homozygous wild-type (WT), homozygous or heterozygous for the ∆ F508mutation (4). Table 1 lists the primers for PCR preparations of the 219-or 222-bp CF target. The two oligomer probes were purchased from Cruachem (Sterling, VA, USA), and Table 1 lists their sequences. The deoxynucleotide probe is complementary to target DNA sequence, except the " A" in bold type with underline. The probe will hybridize the target DNA and generate a G/A mismatch. The A for cleavage is located usually near the center of the probe. Table 1 
Enzyme Assay for Detection of Target DNA
The specific cleavage of G/A mismatch at Aby MR enzymes and the expected size of the cleaved DNA fragment identify the target DNA sequence. The mismatches were generated by annealing the 32 P-labeled probe and the target DNA in MutY assay buffer (5, 19) . The mixture was heated at 90°C for 3 min and then cooled slowly to room temperature to generate DNA heteroduplexes with a G/A mismatch.
In the assay, approximately 1 0 000-20 000 disintegrations per minute (dpm) of the 32 P-labeled heteroduplex substrate were incubated overnight (ca. 6) CF genes. The ∆ F508 gene has a 3-base deletion at codon 508 ( ∆ F508 ). The carrier contains a mutated ∆ F508allele and a normal allele and is a heterozygote. The ∆ F508 probe (lanes 4-6) is a 21-base oligomer that will hybridize the ∆ F508DNA target to generate a G/A mispair with the A at the probe. The WT probe (lanes 1-3) is a 19-base oligomer that will generate a G/A mismatch with the normal DNA target. In the assay, approximately 100 fmol of 32 P-labeled probe and 5 fmol of the target DNA were incubated at 37°C for 5 h with 20 ng cloned MutY enzyme. After the assay, the probes and the cleaved fragments were separated by gel electrophoresis and visualized in the autoradiograph for determining the site of cleavage. M11 is an 11-bp marker.
buffer (20 mM Tris, pH 7.6, 1 mM EDTA and 50 µ g of bovine serum albumin [BSA] per mL). An equal volume of the dye solution was added to a 3-µ L aliquot of the assay mixture to stop the reaction before electrophoresis on a 20% acrylamide gel.
RESULTS AND DISCUSSION
The ∆ F508 is the most common mutant of the CF gene that involves a specific 3-base deletion. Approximately 70% of the CF mutations have the 3-base deletion. During the last few years, we have used the specific cleavage at G/A or G/T mismatch by MR enzymes in the detection of DNA point mutations (5, 19) . The enzymes are very specific and only cut the mispaired DNA duplex at A or T (5, 7, 19) . For practical purposes, the ∆ F508is a good model for developing mismatch cleavage assay in determining deletion mutation.
In experiments with this model, three CF DNA targets of approximate 220 bp were prepared by PCR amplification of genomic DNA from normal and CF patients with ∆ F508in one or both alleles. We also manipulated the T m s of the hybrids and designed the procedure such that at the 37°C assay temperature, the ∆ F508probe will anneal the ∆ F508DNA target but not the normal target. Conversely, the WT probe hybridizes the normal target but not the ∆ F508target. Table 1 To evaluate the sensitivity, the assays were carried out with approximately 100 fmol of WT or ∆ F508probe and decreasing quantities of the normal and the ∆ F508targets. The results in Figure  2 show that the MutY enzyme does not cut single-stranded probe (lane C). Figure 2, lanes 1-3 and 4-6 , further shows that the cleaved products decrease with reducing amounts of DNA target in the assay mixtures. The lowest detection limit is about 1 fmol (Figure 2, lanes 3  and 5) . If one genomic DNA molecule has 3 ×10 9 bases in 10 5 genes, 1 fmol will be approximately 10 12 fg or 1 mg genomic DNA. The assay that requires 1 mg of genomic DNA in 20 µ L incubation mixture is obviously impractical. In addition, the isolation of 1 mg DNA needs 0.3 g or more of human cells. To make simple diagnostic kits for genetic diagnosis, the assay would require a sensitivity able to detect 1 amol or less of the target (i.e., an increase of sensitivity 10 3 -fold from the present assay).
During the last 2-3 years, we have developed a procedure of recycling the DNA target for improving the sensitivity by including the amplifier in the assay. Figure 3 cling of the target and the resulting amplification of mismatch cleavage in the presence of 25 mM (lanes 2 and 2P) or 75 mM (lanes 3 and 3P) of the AA amplifier. In the assay, the DNA hybrid of the probe and the target has a T m of 47°C and a G/A mismatch for cleavage by MutY. During the incubation at 37°C, the MutY enzyme will only cut the A of the G/A mismatch in the probe that anneals the target. In the assay with 3 fmol of target and 100 fmol ∆ F508 probe, the excess, unhybridized probe remains as single-stranded oligomer and is not the substrate for cleavage. They will not be cut by MR enzymes. The A for the mismatch cleavage usually locates near the center of the probe. The cleavage at the mismatched A of the probe will split the probe in half and reduces the T m to approximately 24°-28°C. Because the T m is below the 37°C incubation temperature, the product will dissociate from the target and free the target for another round of annealing and cleavage. However, this does not seem to occur, or if it does, occurs too slowly to be detected without the addition of amplifier (Figure 3, lane  1) . Figure 3, lanes 2 and 2P, shows the increases of sensitivity by 10-fold to 20-fold in the presence of 25 mM amplifier. Figure 3 , lanes 3 and 3P, further shows more amplification of sensitivity with 75 mM of amplifier. Approximately 100 fmol of probe were included in the assay. After a 40-h incubation, more than half (50 fmol) of the input probe were observed as cleaved products in the autoradiogram (lanes 3 and 3P). Since only 3 fmol of target were originally included in the assay, the target must have been used again and again many times (i.e., the amplifier frees the target for recycling). The increase of amplification with increasing concentrations of AA (lanes 2 and 3) is consistent with our previous results (6), supporting that AA competes with mutYfor substrate binding sites and causes the release of target DNA for recycling. Once the substrate DNA binds to AA, the phosphodiester linkage can be broken at the 3 ′ or 5 ′ end or both ends of the deoxy(A). The possible mechanisms of mismatch cleavage and the amplification by amines were previously discussed (6) . Figure 4 further shows that AA at 75 mM recycles the target and increases the sensitivity. As low as a few attomoles of target were identified (lane 8).
Because the lowest detection limit in lane 8 with amplifier is 7 amol, there is a 10 2 -10 3 improvement of sensitivity. Again, in the repeated experiment, the assay yields more product than the target and the uncut probe left in the reaction mixture (lanes 9 and 10). By further modifying the procedure with nonradioactive labels, it is possible to make simple diagnostic kits for testing defective genes at the DNA level without prior target amplification.
